Codexis to Participate at Three Virtual Investment Conferences in November
Codexis, a leader in protein engineering, announced its participation in three virtual investment conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Codexis, a leader in protein engineering, announced its participation in three virtual investment conferences. The events include the Stifel Healthcare Conference on November 16, 2020, at 3:20 p.m. ET, the 11th Annual Craig-Hallum Alpha Select Conference on November 17, 2020, and the Stephens Annual Investment Conference on November 18, 2020, at 1:00 p.m. ET. Presentations will be webcasted and available for replay on the company's investor website. Codexis utilizes its proprietary technology for developing proteins for pharmaceuticals and industrial applications.
Details
News Market Reaction – CDXS
The recorded move for CDXS in the trading session of this news was +6.97%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate at three upcoming virtual investment conferences:
- Stifel Healthcare Conference on Monday, November 16, 2020 with presentation at 3:20 p.m. Eastern time (12:20 p.m. Pacific time)
- 11th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 17, 2020
- Stephens Annual Investment Conference 2020 on Wednesday, November 18, 2020 with presentation at 1:00 p.m. Eastern time (10:00 a.m. Pacific time)
Live webcasts and replays of the presentations at the Stifel Healthcare Conference and Stephens Annual Investment Conference will be available on the Investors section of the company’s website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see www.codexis.com.
Contact:
LHA Investor Relations
Jody Cain, 310-691-7100
jcain@lhai.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.